Considering that restored level of Rnd3 serves as a protective mechanism in heart diseases, development of medications to jack up Rnd3 signaling may be a promising therapeutic approach for DCM and associated cardiac diseases. The gene discussed is RND3; the disease is familial dilated cardiomyopathy.